AI for the assessment and discovery of morphological-molecular biomarker relationships in hematologic malignancies.
AI can now read blood smears like expert pathologists and link appearance to molecular patterns, advancing how we diagnose blood cancers precisely.
This review summarizes AI-driven morphological assessment advances in hematologic malignancies, where deep learning achieves expert-level classification and reveals morphologic-molecular correlations from blood/bone marrow smear images. Key challenges including data heterogeneity, prospective validation needs, and interdisciplinary collaboration are discussed, with AI-powered explainable morphology positioned as advancing precision hematology.
What the study was
- Study design
- Systematic review
- Population
- Patients with myeloid and lymphoid malignancies (literature-based)
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Blood reviews
Why it surfaced
Comprehensive Blood Reviews systematic review on AI morphology-molecular biomarker connections in hematologic malignancies. Multiple watchlist topics matched. Good reference synthesis for pipeline context.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.